A Study to Evaluate the Safety, Tolerability, PK and Efficacy of Hemay5087 in Patients With Advanced Solid Tumors
Clinical trial NCT07624864 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07624864
- Sponsor
- Ganzhou Hemay Pharmaceutical Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-15
- Primary completion
- 2028-04-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.